CardioWise wins health tech award
Fayetteville-based digital healthcare company CardioWise was named a rising star in a health technology awards program hosted by an affiliate of the University of California.
San Francisco-based nonprofit UCSF Health Hub recently announced CardioWise as a rising star in the clinical diagnostic tool category during the 2022 Digital Health Awards. The company was one of four to be named a rising star for the category.
According to a news release, the winners were announced at Zouk Nightclub at Resorts World Las Vegas at the annual HLTH Conference in front of 1,500 guests. CardioWise was previously a finalist in the rising star category for clinical diagnostic tool.
“UCSF is recognized as an expert in digital health and has a superlative reputation,” said Jack Coats, CEO of CardioWise. “For a startup company like CardioWise to have been chosen from over 1,250 applications by a team of 100 prestigious judges, all organized by UCSF, is truly an honor and a tribute to our fine development team led by Geoffrey Dalbow, CardioWise CTO.”
According to the release, finalists were selected across 10 categories by a team of judges in the healthcare and venture capital industries, including Daniel Kraft, CEO of Digital.Health, Ursheet Parikh of Mayfield Fund and Michael Roizen of Cleveland Clinic. Within each category, four finalists were selected for best in class, and eight finalists were chosen for rising star.
Submissions for the fourth annual program rose by 30% to more than 1,250 applicants, including early and late-stage digital health, health information technology, device and diagnostic companies worldwide, said Mark Goldstein, chairman of UCSF Health Hub and general partner at venture capital firm Builders VC.
“These finalists are truly the best of the best and are changing the face of healthcare,” Goldstein said. “Our hundreds of judges are excited to begin the final round of voting today.”
Earlier this year, in collaboration with investor Nex Cubed, GE Healthcare selected CardioWise for the inaugural Edison Accelerator in Canada. CardioWise has developed cloud-based software that uses artificial intelligence to show how well a patient’s heart is functioning or pumping blood.